Photosensitization of human skin fibroblasts by vemurafenib promotes pleiotropic effects on membrane-enclosed organelles and apoptosis

J Photochem Photobiol B. 2023 Jan:238:112600. doi: 10.1016/j.jphotobiol.2022.112600. Epub 2022 Nov 21.

Abstract

Vemurafenib (VB), a BRAF inhibitor and a first-line treatment for unresectable or metastatic melanoma, is strongly phototoxic towards normal skin cells. Herein, we show that in cultured HS 68 human diploid dermal fibroblasts, low concentrations of VB suffice to promote photosensitization to low doses of UVA (∼ 5 J/cm2), as evidenced by a significant decrease in cell viability. In contrast to data obtained in chemico our results support a role for ROS (reactive oxygen species). Indeed, peroxidation of cellular lipids was observed which could be alleviated by the lipophilic antioxidant BHT (2,6-di-tert-butyl-4-methylphenol). Using in vivo confocal laser scanning microscopy and vital fluorescent probes it was shown at the single cell level that the plasma membrane and lipid-rich organelles, namely mitochondria, endoplasmic reticulum, and lysosomes, as well as actin filaments, were severely damaged by the UVA-induced VB-photosensitization. Finally, we showed that mitochondrial impairment was concurrent with caspase 3/7 activation and cell death by apoptosis.

Keywords: Apoptosis; Caspases; ER; Mitochondria; Photoperoxidation; UVA; Vemurafenib.

MeSH terms

  • Apoptosis*
  • Fibroblasts
  • Humans
  • Mitochondria / metabolism
  • Reactive Oxygen Species / metabolism
  • Skin* / metabolism
  • Ultraviolet Rays
  • Vemurafenib / metabolism
  • Vemurafenib / pharmacology

Substances

  • Vemurafenib
  • Reactive Oxygen Species